|
|
| Research article summary (published 29 Sep 2009): |
Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.
Full Abstract
A recent study reported on mutations in the active site of the isocitrate dehydrogenase 1 (IDH1) gene in several types of gliomas. All mutations detected resulted in an amino acid exchange at position 132. We analyzed the genomic region spanning wild-type R132 of IDH1 by direct sequencing in 125 glial tumors. A total of 39 IDH1 mutations were observed. Mutations of the IDH2 gene, homologous to IDH1, were often detected in gliomas without IDH1 mutations. In the present study, R172 mutation of the IDH2 gene was detected in one anaplastic astrocytoma. IDH1 or IDH2 mutations were frequently in oligodendrogliomas (67%), anaplastic astrocytomas (62%), anaplastic oligoastrocytomas (75%), anaplastic oligodendrogliomas (50%), secondary glioblastomas (67%), gangliogliomas (38%), and anaplastic gangliogliomas (60%). Primary glioblastomas were characterized by a low frequency of mutations (5%) at amino acid position 132 of IDH1. Mutations of the IDH1 or IDH2 genes were significantly associated with improved outcome in patients with anaplastic astrocytomas. Our data suggest that IDH1 or IDH2 mutation plays a role in early tumor progression of several types of glioma and might arise from a common glial precursor. The infrequency of IDH1 mutation in primary glioblastomas revealed that these subtypes are genetically distinct entities from other glial tumors.
Author information
Author/s: Sonoda, Yukihiko (Y); Kumabe, Toshihiro (T); Nakamura, Taigen (T); Saito, Ryuta (R); Kanamori, Masayuki (M); Yamashita, Yoji (Y); Suzuki, Hiroyoshi (H); Tominaga, Teiji (T);
Affiliation: Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. sono(-atsign-)nsg.med.tohoku.ac.jp
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Cancer science (Cancer Sci), published in England. (Language: eng)
Reference: 2009-Oct; vol 100 (issue 10) : pp 1996-8
Dates: Created 2009/09/21; Completed 2009/10/09;
PMID: 19765000, status: MEDLINE (last retrieval date: 10/9/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Association of telomerase gene hTERT polymorphism and malignant gliomas.
3 Apr 2007 - New frontiers in the treatment of malignant glioma.
29 Nov 2003 - Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
13 Mar 2008 - PIK3CA mutations in oligodendroglial tumours.
30 Mar 2006 - Mutational analysis of Rac2 in gliomas.
22 Jan 2008 - Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas.
30 Jul 2005 - Analysis of the IDH1 codon 132 mutation in brain tumors.
3 Nov 2008 - Molecular markers of gliomas: a clinical approach.
29 Jun 2006 - Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia.
29 Sep 2006 - Glutathione S-transferase polymorphisms and survival in primary malignant glioma.
13 Apr 2004
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.